Post-neoadjuvant Metabolic Response Assessed by ¹⁸F-FDG PET/CT Predicts Pathologic Complete Response and Survival in Esophageal Squamous Cell Carcinoma Treated with the CROSS Regimen.
Saved in:
| Title: | Post-neoadjuvant Metabolic Response Assessed by ¹⁸F-FDG PET/CT Predicts Pathologic Complete Response and Survival in Esophageal Squamous Cell Carcinoma Treated with the CROSS Regimen. |
|---|---|
| Authors: | Moorthy S; Department of Surgical Oncology, Cancer Institute (WIA), Chennai, India., Arvind K; Department of Surgical Oncology, Cancer Institute (WIA), Chennai, India. drarvindkrishnamurthy@yahoo.co.in.; Department of Surgical Oncology, Cancer Institute, Chennai, India. drarvindkrishnamurthy@yahoo.co.in., Surianarayanan P; Department of Surgical Oncology, Kidwai Memorial, Bengaluru, India., P N; Department of Surgical Oncology, Cancer Institute (WIA), Chennai, India., V M; Department of Surgical Oncology, Cancer Institute (WIA), Chennai, India. |
| Source: | Journal of gastrointestinal cancer [J Gastrointest Cancer] 2026 May 22; Vol. 57 (1). Date of Electronic Publication: 2026 May 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101479627 Publication Model: Electronic Cited Medium: Internet ISSN: 1941-6636 (Electronic) NLM ISO Abbreviation: J Gastrointest Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1941-6636 |
|---|---|
| DOI: | 10.1007/s12029-026-01485-z |
